… flecainide prevents exercise-induced ventricular arrhythmias in those with significant ventricular
… We provided a higher level of evidence supporting flecainide use for treatment of CPVT …

… before treatment is started."2 A further attraction of flecainide is that it can be used for
ventricular tachycardias. These are much less common prenatally but do occur.'3 …

… ventricular arrhythmia during flecainide use. Two patients with chronic atrial fibrillation had
arrhythmia during vigorous exercise despite absence of significant ventricular arrhythmia …

… fetuses with supraventricular tachycardia in a median time of 3 days. In our opinion, flecainide
should be considered as first-line therapy in fetal supraventricular tachycardia with and …

… used flecainide for the treatment of fetal supraventricular … with supraventricular tachycardia
treated with flecainide, either … to demonstrate safety and effectiveness of this treatment. …

… Another potential limitation is that we only quantified the effect of flecainide on exercise-induced
ventricular arrhythmias, which may not accurately predict fatal arrhythmic events. …

… 12 days on placebo compared with more than 55 days on flecainide (p<0.001). Finally, the …
the placebo and flecainide treatment phases. In summary, flecainide significantly reduces the …

… 2006, we used flecainide to treat 20 consecutive newborns (15 males… The intravenous
administration of flecainide (1 mg/kg) … failure or sustained ventricular tachycardia during follow-up. …

… arrhythmia centers that have used flecainide to treat patients with nonsustained ventricular
tachycardia who had had previous unsuccessful treatment with other antiarrhythmic drugs. …

… ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease that can cause sudden
cardiac death due to ventricular fibrillation … flecainide can effectively suppress arrhythmia …